1. Home
  2. TAC vs MMED Comparison

TAC vs MMED Comparison

Compare TAC & MMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TransAlta Corporation

TAC

TransAlta Corporation

HOLD

Current Price

$12.99

Market Cap

3.5B

Sector

Utilities

ML Signal

HOLD

MMED

MiniMed Group Inc. Common Stock

N/A

Current Price

$11.08

Market Cap

4.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TAC
MMED
Founded
1909
1983
Country
Canada
United States
Employees
1350
N/A
Industry
Electric Utilities: Central
Medical/Dental Instruments
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
4.1B
IPO Year
N/A
2026

Fundamental Metrics

Financial Performance
Metric
TAC
MMED
Price
$12.99
$11.08
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
10
Target Price
$23.67
$22.56
AVG Volume (30 Days)
952.2K
641.5K
Earning Date
05-06-2026
06-03-2026
Dividend Yield
1.57%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$15.99
Revenue Next Year
$6.48
$10.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.73
$11.02
52 Week High
$17.88
$17.86

Technical Indicators

Market Signals
Indicator
TAC
MMED
Relative Strength Index (RSI) 54.34 33.13
Support Level $12.09 N/A
Resistance Level $14.00 $15.80
Average True Range (ATR) 0.42 0.72
MACD 0.05 -0.04
Stochastic Oscillator 83.60 5.70

Price Performance

Historical Comparison
TAC
MMED

About TAC TransAlta Corporation

TransAlta Corp is an independent power producer based in Alberta, Canada. The company operates a diverse electrical power generation assets in Canada, the United States, and Western Australia. The company has reportable segments namely, Hydro, Wind & Solar, Gas, Energy Transition segment and Corporate Segment. The company generates the majority of its revenue from the gas segment.

About MMED MiniMed Group Inc. Common Stock

Minimed Group Inc is a medical technology firm that develops, manufactures, and markets products and solutions for diabetes management. It offers automated insulin pumps, continuous glucose monitoring systems and sensors, and smart insulin pens as its main products. The company sells these through direct-to-consumer channels and healthcare providers of various countries. The company's revenues are principally derived from the sale of reusable and single-use products which together comprise AID systems and smart multiple daily injection (MDI) systems for diabetes management to individuals, distributors, healthcare providers, and other institutions globally.

Share on Social Networks: